|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
SEOULBIOHUB
|
SEOUL BIOHUB
|
|
C401
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
서울특별시청
|
SEOUL BIOHUB
|
|
C401
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
SinoBiological
|
LONZA Cocoon, Nucleofector System, SINO Antibody, Cytokine
|
|
B101
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
시노바이오로지컬
|
Custom Service, Recombinant Protein, Antibody, cDNA, ELISA Kit
|
|
C201
|
|
[KOREA LAB Autumn] Laboratory and R&D Equipment
|
SMARTJACKCo.Ltd.
|
LABMANAGER PRO
|
|
E106
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
무맥동정량이송다이어프램펌프
|
Smoothflow Pump
|
|
B108
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
SNBioScience
|
Nanodrug Delivery Technology for Anticancer Agents
|
|
E506
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
SNKTherapeutics
|
SNK Therapeutics is a biotechnology company dedicated to the development of innovative new drugs targeting autoimmune and inflammatory diseases. The company’s flagship pipeline includes SK101, a small molecule therapy targeting autoimmune diseases such as psoriasis and systemic lupus erythematosus through TLR inhibition. Another pipeline asset, SK201, focuses on inflammatory diseases like metabolic fatty liver disease and Alzheimer’s, utilizing NLRP3 inflammasome inhibition. SK301 targets rheumatoid arthritis and other inflammation-related diseases through TNF inhibition, with promising results in animal models. Employing an AI-driven drug discovery platform, SK Therapeutics accelerates the discovery and expansion of indications, improving the efficiency and accuracy of drug development.
|
|
E506
|
|
[KOREA LAB Autumn] Laboratory and R&D Equipment
|
SPLLIFESCIENCE
|
Media, FBS, LABWARE
|
|
C504
|
|
[KOREA LIFE SCIENCE WEEK] Bio·Medical·Pharma
|
SS&CIntralinks
|
VDR (Virtual Data Room) for License-out, R&D etc.
|
|
B503
|
KYUNGYON EXHIBITION CORP.